Clinical Nuclear Medicine

Skip Navigation LinksHome > February 2014 - Volume 39 - Issue 2 > Potential Role of FDG PET/CT in Evaluating Patients With Hep...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0000000000000312
Review Article

Potential Role of FDG PET/CT in Evaluating Patients With Hepatic Incidentalomas

Grassetto, Gaia MD*; Marzola, Maria Cristina MD*; Chondrogiannis, Sotirios MD*; Maffione, Anna Margherita MD*; Rampin, Lucia MD*; Galeotti, Fabrizio MD; Colletti, Patrick M. MD; Rubello, Domenico MD*

Collapse Box


Abstract: This review article is focused on the role of FDG PET/CT in diagnosing and characterizing hepatic incidentalomas. A large variety of unsuspected lesions can be detected in the liver both with ultrasound and CT performed for other reasons; the prevalence of liver incidentalomas increases in patients with chronic liver disease or preexisting oncologic history. The major challenge is to discriminate benign from malignant lesions. There is a large body of literature indicating that FDG PET/CT is a useful tool to this purpose even if it is unspecific (ie, it cannot differentiate a primary tumor from a secondary lesion). Occasionally, FDG PET/CT can be useful for biopsy guidance.

© 2014 by Lippincott Williams & Wilkins


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.